EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype

Federico Bocci, Satyendra C Tripathi, Samuel A Vilchez Mercedes, Jason T George, Julian P Casabar, Pak Kin Wong, Samir M Hanash, Herbert Levine, José N Onuchic, Mohit Kumar Jolly

Integrative Biology · 01.06.2019 · 11 (6) · 251-263

DOI: 10.1093/intbio/zyz021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrative Biology, online erschienen am 22.07.2019. Verfasst von Federico Bocci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Theoretical Biological Physics, Rice University, Houston, TX, USA. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Science Foundation, Center for Theoretical Biological Physics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epithelial-mesenchymal transition (EMT) is a key process implicated in cancer metastasis and therapy resistance. Recent studies have emphasized that cells can undergo partial EMT to attain a hybrid epithelial/mesenchymal (E/M) phenotype – a cornerstone of tumour aggressiveness and poor prognosis. These cells can have enhanced tumour-initiation potential as compared to purely epithelial or mesenchymal ones and can integrate the properties of cell-cell adhesion and motility that facilitates collective cell migration leading to clusters of circulating tumour cells (CTCs) – the prevalent mode of metastasis. Thus, identifying the molecular players that can enable cells to maintain a hybrid E/M phenotype is crucial to curb the metastatic load. Using an integrated computational-experimental approach, we show that the transcription factor NRF2 can prevent a complete EMT and instead stabilize a hybrid E/M phenotype. Knockdown of NRF2 in hybrid E/M non-small cell lung cancer cells H1975 and bladder cancer cells RT4 destabilized a hybrid E/M phenotype and compromised the ability to collectively migrate to close a wound in vitro. Notably, while NRF2 knockout simultaneously downregulated E-cadherin and ZEB-1, overexpression of NRF2 enriched for a hybrid E/M phenotype by simultaneously upregulating both E-cadherin and ZEB-1 in individual RT4 cells. Further, we predict that NRF2 is maximally expressed in hybrid E/M phenotype(s) and demonstrate that this biphasic dynamic arises from the interconnections among NRF2 and the EMT regulatory circuit. Finally, clinical records from multiple datasets suggest a correlation between a hybrid E/M phenotype, high levels of NRF2 and its targets and poor survival, further strengthening the emerging notion that hybrid E/M phenotype(s) may occupy the ‘metastatic sweet spot’.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticAntigens, CDCadherinsCarcinoma, Non-Small-Cell LungCell AdhesionCell Line, TumorCell MovementEpithelial CellsGene Knockdown TechniquesHumansKaplan-Meier EstimateLung NeoplasmsModels, TheoreticalNF-E2-Related Factor 2Neoplasm MetastasisNeoplastic Cells, CirculatingPhenotypePrognosisUrinary Bladder NeoplasmsZinc Finger E-box-Binding Homeobox 1

Substanzen

Antigens, CDCDH1 protein, humanCadherinsNF-E2-Related Factor 2NFE2L2 protein, humanZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Autor:innen und Institutionen

  • Center for Theoretical Biological Physics, Rice University, Houston, TX, USA.
  • Department of Chemistry, Rice University, Houston, TX, USA.
  • Department of Clinical Cancer Prevention, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Current address: Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, India.
  • Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, USA.
  • Department of Bioengineering, Rice University, Houston, TX, USA.

Förderung

  • NCI NIH HHS
  • National Science Foundation
  • Center for Theoretical Biological Physics
  • CHE
  • MCB
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health
  • Computational Cancer Biology Training Program

Zitieren

APA

Bocci, F., Tripathi, S. C., Vilchez Mercedes, S. A., George, J. T., Casabar, J. P., Wong, P. K., Hanash, S. M., Levine, H., Onuchic, J. N., & Jolly, M. K. (2019). NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype. Integrative Biology, 11(6), 251-263. https://doi.org/10.1093/intbio/zyz021

Vancouver

Bocci F, Tripathi SC, Vilchez Mercedes SA, George JT, Casabar JP, Wong PK, et al. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype. Integrative Biology. 2019;11(6):251-263. doi:10.1093/intbio/zyz021

BibTeX
@article{Bocci2019,
  author = {Bocci, Federico and Tripathi, Satyendra C and Vilchez Mercedes, Samuel A and George, Jason T and Casabar, Julian P and Wong, Pak Kin and Hanash, Samir M and Levine, Herbert and Onuchic, José N and Jolly, Mohit Kumar},
  title = {NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype},
  journal = {Integrative Biology},
  year = {2019},
  volume = {11},
  number = {6},
  pages = {251--263},
  doi = {10.1093/intbio/zyz021}
}
Kostenlos starten →